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A B S T R A C T
Several investigations have demonstrated neuroprotective effects of quercetin, a polyphenol widely present in
nature, against neurotoxic chemicals, as well as in neuronal injury/neurodegenerative disease models. Most of
these studies have been performed with quercetin aglycone and its metabolites, while scanty data are available
on its glycosides. This study is aimed at investigating the neuroprotective effects of quercetin 3,4’-O-β-D-di-
glucoside (Q3,4’dG), isolated from the bulbs of the white cultivar (Allium cepa L.), using an in vitro model of
human striatal precursor cells (HSPs), a primary culture isolated from the striatal primordium and previously
characterized. To study the effect of Q3,4’dG on cell survival, HSPs were exposed to nutrient deprivation created
by replacing culture medium with phosphate buffer saline (PBS). Our findings showed that Q3,4’dG treatment
significantly promoted cell survival and strongly decreased apoptosis induced by nutrient deprivation, as
evaluated by cell proliferation/death analyses. In addition, since the adhesive capacities of cells are essential for
cell survival, the expression of some adhesion molecules, such as pancadherin and focal adhesion kinase, was
evaluated. Interestingly, PBS exposure significantly decreased the expression of both molecules, while in the
presence of Q3,4’dG this effect was prevented.
This study provides evidence of a neuroprotective role exerted by Q3,4’dG and suggests its possible im-
plication in sustaining neuronal survival for prevention and treatment of neurodegenerative disorders.
1. Introduction
Epidemiological studies have shown that a reduced risk of degen-
erative diseases is correlated with a regular consumption of fruits and
vegetables, many of which are rich in polyphenols (Stanner et al.,
2004). Flavonoids represent a class of phenolic metabolites with sig-
nificant antioxidant and chelating properties, and several studies have
demonstrated the beneficial effects of flavonoid-rich foods as anti-in-
flammatory and anticancer agents, as well as their protective role in
degenerative diseases, including cardiovascular and neurodegenerative
disorders and age related neuronal decline, both in humans and animal
models (Dajas, 2012; Ferreres et al., 2013; Guerra-Araiza et al., 2013;
Kling et al., 2014; Costa, 2014; Fernandes et al., 2017).
One of the most abundant sources of flavonoids are the onion bulbs
(Allium cepa L.), particularly rich in quercetin and its glycosides,
quercetin 4’-O-β-D-glucoside and quercetin 3,4’-O-β-D-diglucoside,
which account for more than 85% of the total flavonoid content
(Slimestad et al., 2007; Corzo-Martinez et al., 2007). Scientific reports
indicate that onion has biological activities, such as general anti-
oxidant, anti-inflammatory, antimicrobial, antiallergic and neuropro-
tective properties (Shri and Singh Bora, 2008; Sato et al., 2015; Singh
and Goel, 2015). Thus, many antioxidants have been tested in various
in vitro and in vivo neurodegenerative models. Among flavonoids,
quercetin is the most studied but the mechanisms through which
quercetin exerts its neuroprotective effects are not fully elucidated,
although various hypotheses have been made. In addition to direct
antioxidant effect, it has been demonstrated that quercetin modulates
intracellular signaling and transcription factors, increasing the expres-
sion of antioxidant and pro-survival proteins and downregulating in-
flammation. Quercetin also regulates the activity of kinases, changing
the phosphorylation state of target molecules, resulting in modulation
of cellular function and gene expression (Dajas et al., 2015). Most of
these studies has been performed on quercetin aglycone and its meta-
bolites, while scanty data, but interesting, are available on its
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glycosides. Of note, glycoside forms of quercetin, as rutin (quercetin-3-
O-rutinoside) and isoquercetin (quercetin 3-O-glucoside), abundant in
many fruits and vegetables, have demonstrated a significant neuro-
protective effect against neurotoxicity induced by 6-hydroxydopamine
(6-OHDA) in PC12 neuronal cells, a good in vitro model of Parkinson’s
disease (PD) (Magalingam et al., 2013, 2014, 2015a,b, 2016). Other
studies revealed that hyperoside (quercetin 3-O-β-D-galactoside),
mainly extracted from Hypericum perforatum L., has protective effects
against neuronal ischemia-reperfusion (Liu et al., 2012) and β-amyloid
protein-induced impairment (Zeng et al., 2011) in cultured cortical
neurons of rats. However, no data are present in literature on possible
effects of quercetin 3,4’-O-β-D-diglucoside and quercetin 4’-O-β-D-di-
glucoside, the two most abundant glycosides in Allium cepa.
The striatum is a brain area localized in a non-neurogenic region of
the basal forebrain crucially involved in the complex cortico-basal
ganglia network governing planned and motivated behaviours through
motor, cognitive, and limbic circuits (Obeso et al., 2008; O’Callaghan
et al., 2014). Indeed, the impairment of these brain functions is hall-
mark of neurodegenerative disorders such as PD and Huntington’s
disease (HD), both associated to striatal dysfunction (O’Callaghan et al.,
2014). The striatal primordium originates during development in the
ganglionic eminence, a conspicuous domain of the telencephalic pro-
liferative zone (Ulfig, 2000). The striatal neuronal precursors divide,
migrate, and differentiate establishing both intrinsic and afferent/ef-
ferent connections responsible for the basal ganglia circuits (Evans
et al., 2012).
In the present study, we aimed at investigating the neuroprotective
effects of quercetin 3,4’-O-β-D-diglucoside (Q3,4’dG) (Fig. 1), isolated
from the bulbs of the white cultivar (Allium cepa L.) grown in Molise
region (Italy), using an in vitro model of human striatal precursor cells
(HSPs). These cells are primary cultures recently established by our
research group isolating the striatal primordium from the ganglionic
eminence of 9–12 weeks old human fetuses (Sarchielli et al., 2014).
HSPs were extensively characterized (Sarchielli et al., 2014) and re-
capitulate the cell composition of the striatum during development,
being a mixed population of neural stem cells, neuronal-restricted
progenitors and striatal neurons that express and are responsive to
neurotrophins, such as brain derived neurotrophic factor and fibroblast
growth factor-2 (Sarchielli et al., 2014). Moreover, HSPs showed an
adaptive response to stress conditions, such as nutrient deprivation
(Sarchielli et al., 2014) and hypoxia (Ambrosini et al., 2015), which
characterize the neurodegenerative processes, when the loss of neurons
is accompanied by a reduced astrocyte- and blood vessel-mediated
trophic support (Cisbani et al., 2013). Hence, HSPs were exposed to
nutrient deprivation by replacing the culture medium with phosphate
buffer saline (PBS) in order to evaluate Q3,4’dG role in promoting cell
survival.
2. Material and methods
2.1. Quercetin 3,4’-O-β-D-diglucoside extraction
Bulbs of Allium cepa L. were extracted with MeOH for 12 h at room
temperature, concentrated and subjected to a modified Kupchan’s
partitioning procedure (Kupchan et al., 1973; De Marino et al., 2012).
The n-BuOH fraction was submitted to DCCC (Droplet Counter-Current
Chromatography) with n-BuOH/Me2CO/H2O (3:1:5) on a DCC-A ap-
paratus (Tokyo Rikakikai Co., Tokyo, Japan) equipped with 250 glass-
columns. Six fractions A-F were obtained and purified by HPLC using a
Waters 510 pump equipped with a Rheodyne 7125 injector and a
Waters 401 differential refractometer as detector, on a Nucleodur 100-5
C18 column (5 μm, 250mm×4.6mm i.d.; Macherey-Nagel, GmbH &
Co. KG), flow rate 1.0 ml/min. Fraction C was separated with 35% of
aqueous MeOH+0.1% trifluoroacetic acid (TFA) as eluent to give
mainly quercetin 3,4’-O-β-D-diglucoside (Q3,4’dG) which was identified
on the basis of spectroscopic data from 1D and 2D NMR experiments
(Varian Inova 500 NMR spectrometer, 1H at 500MHz and 13C at
125MHz equipped with a Sun hardware) and ESI–MS spectral analyses
(ESI–MS: Applied Biosystem API 2000 triple-quadrupole mass spectro-
meter). MeOH (methanol, RCI Labscan Ltd. HPLC grade); n-BuOH (n-
buthanol, RCI Labscan Ltd., AR grade); Me2CO (acetone, RCI Labsca
Ltd., AR grade); H2O (water, RCI Labsca Ltd., AR grade); TFA (tri-
fluoroacetic acid, Sigma-Aldrich).
2.2. Cell cultures
HSP cells were prepared as previously described (Sarchielli et al.,
2014). Briefly, striatal tissue from 9 to 12 weeks old legally aborted
human fetuses were obtained according to Italian National Institute of
Health ethical guidelines. The use of human fetal tissue for research
purposes was approved by the National Ethics Committee and the
Committee for investigation in Humans of the University of Florence
(Protocol n° 678304) (Gallina et al., 2008, 2010, 2014). Striatal tissue
was dissected from 3 human fetuses under sterile conditions, cut into
fragments and enzymatically digested by 1mg/ml collagenase type IV
(Sigma-Aldrich Corp., St. Louis, MO, USA) incubation. The cell sus-
pensions were mechanically dispersed by pipetting in Coon’s modified
Ham's F12 medium (catalog No. ECM0019L, Euroclone, Milan, Italy)
supplemented with 10% fetal bovine serum (FBS, catalog No.
CHA1115L, Hyclone, Logan, UT, USA) and cultured at 37 °C in 5% CO2
atmosphere. Confluent cells were split to 1:2–1:4 ratio using EDTA-
trypsin solution, and used within the 15th passage.
2.3. MTT assay
Cell viability was determined by MTT assay (catalog No. 96992,
Sigma–Aldrich Corp.). Briefly, 8× 103 HSP cells were seeded in 96-well
plates in Coon’s modified Ham’s F12 medium supplemented with 10%
FBS. After 24 h cells were maintained in serum-free medium for 8 h and
Fig. 1. Chemical structure of quercetin 3,4’-O-β-D-diglucoside.
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subsequently incubated for 20 h in serum-free medium or in PBS
without Ca2+ and Mg2+ (Euroclone) containing or not increasing doses
of Q3,4’dG (0–500 μM). Then the medium was changed and 10 μl of
MTT solution was added for 3 h at 37 °C. The optical density was
measured at 450 nm using a Multiskan FC spectrophotometer (Thermo
Fisher Scientific, Milan, Italy). Cell viability was expressed as percen-
tage of viable cells over control, taken as 100%, and is the result of six
experiments performed in triplicate.
2.4. Trypan blue staining
5×104 cells were seeded in 24-well plates, starved for 8 h in serum-
free medium and incubated in serum-free medium or PBS in the pre-
sence or absence of 100 μM Q3,4’dG for 20 h. Thereafter, cells were
trypsinized and stained with 0,4% Trypan Blue before the hemocyt-
ometer count. Cell death results were expressed as percentage of Trypan
Blue positive cells (mean ± SEM) from four independent experiments
(10 counts for each experiment).
2.5. Western blotting
Western blot analysis was performed as previously described
(Sarchielli et al., 2014). Briefly, HSP cells were grown in F12 Coon's
Modification Medium supplemented with 10% FBS for 24 h, maintained
in serum-free medium for 8 h and subsequently incubated for 20 h in
serum-free medium or in PBS in the presence or absence 100 μM
Q3,4’dG. Protein extracts were obtained in standard lysis buffer sup-
plemented with protease and phosphatase inhibitor cocktails (Sigma-
Aldrich Corp.); protein concentration was measured with Coomassie
protein assay kit (catalog No. 500-0006, Bio-Rad Laboratories Inc.,
Hercules, CA, USA) and aliquots containing 20 μg of proteins were
loaded on SDS-PAGE. Proteins were then transferred on polyvinylidene
difluoride membranes (Amersham Biosciences, Little Chalfont, UK),
blocked in 3% BSA and incubated with the following primary anti-
bodies: rabbit polyclonal anti-Ki-67 (1:1000; catalog No. ab15580,
RRID:AB_443209, Abcam, Cambridge, UK), mouse monoclonal anti-β
actin (1:10000, catalog No. sc-47778, RRID:AB_626632, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-BAX
(1:1000, catalog No. sc-526, RRID:AB_2064668, Santa Cruz Bio-
technology), rabbit polyclonal anti-Bcl-2 (1:2000, catalog No. 2876,
RRID:AB_2064177, Cell Signaling Technology, Danvers, MA, USA),
mouse monoclonal anti-Pancadherin (1:1000, catalog No. C1821,
RRID:AB_476826, Santa Cruz Biotechnology), rabbit polyclonal anti-
FAK (1:2000, catalog No. sc-558, RRID:AB_2300502, Santa Cruz Bio-
technology). The incubation with the primary antibodies was followed
by peroxidase conjugated secondary IgG treatment (catalog No. sc-2004
and sc-2005, Santa Cruz Biotechnology) and the reacted proteins were
revealed by the enhanced chemiluminescence system (catalog No.
EMP013001, Euroclone). Image acquisition and densitometric analysis
were performed with Quantity One software on a ChemiDoc XRS in-
strument (Bio-Rad Laboratories Inc.) and using β actin for normal-
ization.
2.6. Statistical analysis
Results were expressed as mean ± standard deviation (SD) or
Fig. 2. Effect of Q3,4’dG on cell viability and proliferation. a)
MTT assay of HSPs shows that the exposure to Q3,4’dG (100
nM–500 μM) for 20 h in standard medium does not affect cell
survival at any concentration; the incubation of HSPs in PBS
determines a remarkable reduction of viability compared to
cells maintained in standard medium and the addition of
Q3,4’dG to PBS significantly increases cell proliferation at all
the tested concentrations; ###p < 0.001 PBS vs. standard
medium; *p < 0.05 PBS+Q3,4’dG vs. PBS. Data are ex-
pressed as percentage of standard medium taken as 100%,
and reported as mean ± SEM from six independent experi-
ments performed in triplicate. b) Trypan Blue staining shows
a noteworthy increased number of death (Trypan Blue posi-
tive) cells in nutrient deprivation condition respect to control
(#p < 0.05 PBS vs. CTL); the addition of Q3,4’dG 100 μM to
PBS is able to decrease the number of stained cells to the
control level (**p < 0.005 PBS+Q3,4’dG vs. PBS). Data are
expressed as percentage of Trypan Blue positive cells
(mean ± SEM) from four separate experiments (10 counts
for each experiment). c) Western blot analysis of Ki-67 ex-
pression shows an evident reduction of Ki-67 protein ex-
pression in cells maintained in PBS respect to standard
medium (CTL); the addition of Q3,4’dG 100 μM to PBS pre-
vents the Ki-67 reduction, keeping the protein at the control
level. The bar graph shows the computer assisted quantifi-
cation of Ki-67 band intensity from three separate experi-
ments: data are normalized over β actin signal and are re-
ported as mean ± SD, taking control as 100%; #p < 0.05
PBS vs. CTL; *p < 0.05 PBS+Q3,4’dG vs. PBS.
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±standard error of the mean (SEM) for n experiments. Data were
analyzed statistically by t-test and one-way analysis of variance
(ANOVA) with post-hoc Bonferroni's correction for multiple compar-
isons and p < 0.05 was considered significant. Statistical analysis was
performed with the Statistical Package for the Social Sciences (version
23.0; SPSS Inc., Chicago, IL, USA) for Windows.
3. Results
3.1. Effect of Q3,4’dG on HSPs proliferation and viability during nutrient
deprivation
The effect of nutrient deprivation and Q3,4’dG treatment was first
analyzed by MTT test, a colorimetric assay for assessing cell metabolic
activity. The exposure to increasing concentrations of Q3,4’dG (100
nM–500 μM) for 20 h in standard medium did not affect cell prolifera-
tion/viability (Fig. 2a), demonstrating the lack of cytotoxic effects of
the flavonoid even at higher concentrations. The incubation of HSP
cells in PBS for 20 h determined a remarkable reduction of cell viability
compared to control cells maintained in Ham's F12 medium
(p < 0.001 PBS vs. control); the addition of Q3,4’dG significantly in-
creased cell proliferation/metabolism at all the tested concentrations,
when compared to PBS alone (p < 0.05 PBS+Q3,4’dG vs. PBS)
(Fig. 2a). On the basis of the data present in literature concerning other
quercetin glycosides, a dose of Q3,4’dG 100 μM was chosen to perform
the subsequent experiments (Magalingam et al., 2013, 2015a, 2016).
MTT results were confirmed by the Trypan blue staining of dead
cells; as shown in Fig. 2b the percentage of Trypan blue positive cells
dramatically increased after PBS exposure (8,74% ± 2,46% control vs.
22,41% ± 4,72% PBS, p < 0.05). The addition of Q3,4’dG 100 μM to
PBS was able to lower the percentage of stained cells at
7,29% ± 1,90% (PBS+Q3,4’dG vs. PBS, p < 0.005). We next ana-
lyzed the protein expression of Ki-67, a protein necessary for the cel-
lular proliferation and present during all active phases of the cell cycle
(G1, S, G2, and mitosis), but absent in resting cells (G0). Western blot
analysis revealed a strong reduction of Ki-67 expression in PBS-exposed
cells (20 h; p < 0.05 vs. control), an effect significantly prevented and
normalized to the control level by the addition of 100 μM Q3,4’dG
(p < 0.05 vs. PBS; p= 0.1 vs. control; Fig. 2c).
Thereafter, we investigated whether PBS affected apoptotic index,
as evaluated by western blot analysis of Bax (apoptotic activator)/Bcl-2
(survival promoter) ratio. As shown in Fig. 3, PBS incubation sig-
nificantly increased Bax/Bcl2 ratio, indicating the activation of apop-
tosis (p < 0.05 vs. control), while the addition of Q3,4’dG (100 μM for
20 h) significantly counteracted this phenomenon (p < 0.05 vs. PBS),
although without bringing the Bax/Bcl-2 ratio to the control level
(p < 0.05 vs. control).
3.2. Influence of Q3,4’dG administration on HSPs morphology and
adhesion molecule’s expression in nutrient deprivation condition
The morphological aspect of HSP cells, evaluated with phase con-
trast microscope, confirmed all the previous observations (Fig. 4a). In
fact, cells maintained in medium supplemented or not with Q3,4’dG
100 μM appeared flattened and with a spindle shaped fibroblast-like
morphology (Fig. 4a A, D); conversely PBS determined a massive de-
tachment from the plate and the acquisition of a round shape, typical of
dying cells (Fig. 4a B). Interestingly, the simultaneous treatment with
PBS and Q3,4’dG (100 μM for 20 h) maintained the aspect of adherent
cells with extended cytoplasmic processes, more similar to control cells
(Fig. 4a C).
To further investigate the effect of PBS and Q3,4’dG on cell adhesive
capacities, the expression of the intercellular adhesion molecule
Pancadherin and the extracellular matrix (ECM) adhesion molecule
Focal Adhesion Kinase (FAK) was evaluated by western blot analysis
(Fig. 4b,c). The results showed that PBS exposure determined a strong
decrease in both the analysed adhesion molecules (p < 0.05 vs. con-
trol), while Q3,4’dG was able to increase significantly the two proteins
(p < 0.05 vs. PBS). In particular, Pancadherin was brought back to the
control level (p= 0.23 vs. control), while FAK remained significantly
lower than control (p < 0.001 vs control).
4. Discussion
In the last 20 years, there has been an explosion of studies on the
neuroprotective effects of various fruits and vegetables due to their
bioactive components, particularly the flavonoids (Magalingam et al.,
2015b). Among vegetables the onion, Allium cepa, is rich in flavonoids
and has been demonstrated to have neuroprotective proprieties mainly
attributed to its principal flavonoid quercetin (Shri and Singh Bora,
2008; Singh and Goel, 2015; Yang et al., 2013; Lee and Jung, 2016).
In the present study, we tested and demonstrated for the first time
the benefic effect of Q3,4’dG, one of the most abundant quercetin
glycosides of onion, on some fundamental survival features of human
striatal precursor cells (HSPs) in nutrient deprivation environment, as
stress condition. The findings showed a strong reduction of viability and
cell proliferation of HSP cells and an increase in apoptosis in nutrient
deprivation (PBS) comparing to control cells, while the addition of
Q3,4’dG to PBS reverted this phenomenon promoting cell viability/
proliferation.
No data are present in literature regarding the effect of quercetin
and/or its derivatives on adult or fetal striatal cell cultures in different
stress conditions. However, in vivo investigations in animal models of
HD and PD showed some and different benefic effects of quercetin on
adult striatum. In 3-Nitropropionic acid-induced rat model of HD
quercetin showed to attenuate some behavioral (anxiety, motor co-
ordination deficits, gait despair), neurochemical (reduction of serotine
Fig. 3. Western blot analysis of Bax and Bcl-2 expression in HSP cells untreated (CTL) or
treated with Q3,4’dG 100 μM for 20 h in Coon's modified Ham's F12 medium or PBS. PBS
incubation increases the levels of Bax and decreases Bcl-2; the addition of Q3,4’dG
100 μM significantly reverts this phenomenon. The bar graph shows Bax/Bcl-2 ratio after
the normalization of each signal with the respective β actin staining. The ratio increases
in cells exposed to PBS and decreases after the addition of Q3,4’dG 100 μM, although not
reaching the control level, but indicating an active role of Q3,4’dG to counter apoptosis.
Data are reported as mean ± SD from three separate experiments, taking CTL as 1;
#p < 0.05 PBS vs. CTL, §p < 0.05 PBS+Q3,4’dG vs. PBS, °p < 0.05 PBS+Q3,4’dG vs.
control.
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metabolism) and striatal neuropathological features characteristic of
this pathology. In particular, quercetin administration did not reduce
striatal neuronal lesion, but increased astrocytes number and decreased
microglial proliferation, confirming its anti-inflammatory effect
(Chakraborty et al., 2014; D’Andrea, 2015). Moreover, investigations
on striatum in 6-hydroxydopamine (6-OHDA)-induced rat model of PD
demonstrated that quercetin treatment defended against oxidative
stress and increased neuronal survivability and the level of striatal
dopamine (Haleagrahara et al., 2011, 2013). In addition, several studies
demonstrated the neuroprotective effects exerted by some quercetin
glycosides such as rutin, isoquercetin and hyperoside in in vitro neu-
ropathological models. As an instance, investigations on 6-OHDA-in-
duced rat PC12 cells, an in vitro PD model, demonstrated that rutin and
isoquercetin have not only a benefic effect on viability and on anti-
oxidant machinery, but also have a direct antioxidant action
(Magalingam et al., 2013, 2014, 2016) and modulate several genes to
prevent neuronal cell death (Magalingam et al., 2015a). It is note-
worthy that rutin has been demonstrated to have more neuroprotective
effect with respect to isoquercetin, inducing higher cell viability and
better functionality of some antioxidant enzymes. This seems to be
correlated with their structure; rutin has two monosaccharide units
(glucose 1→ 6 rhamnose) at C-3 position, while isoquercetin has only a
glucose unit, so rutin seems to have higher solubility, stability and
better interaction with antioxidant machinery (Magalingam et al.,
2016). A study on an in vitro ischemic model of oxygen–glucose de-
privation followed by reperfusion (OGD-R) provided evidence that
hyperoside, which contains a galactose unit, has a protective effect on
cortical neurons with a decrease of NO production via inhibition of NF-
kB activation and ameliorating ERK, JNK and Bcl-2 family-related
apoptotic signaling pathways (Liu et al., 2012). Another investigation
on β-amyloid protein (Aβ)-treated primary rat cortical neurons showed
that hyperoside seems to protect from cell death via PI3K/Akt/Bad/
BclXL-regulated mitochondrial apoptotic pathway (Zeng et al., 2011).
Moreover, this study suggests that hyperoside neuroprotective effect
may mainly originate from its galactoside-derivative structure, not its
basic aglycone structure. In fact, quercetin had no effect on Aβ-induced
neurotoxicity in rat cortical neurons (Wang et al., 2001).
Our findings confirm the benefic effect of quercetin, particularly one
of its glycosides, also in other stress conditions; in fact, Q3,4’dG can
maintain neuron viability and proliferation and protect from apoptotic
process in nutrient deprivation environment, probably through some of
the same mechanisms disclosed in the above-mentioned studies. It is
Fig. 4. Q3,4’dG effect on cell adhesion. a) Phase contrast
microphotographs of cells maintained in medium supple-
mented or not with Q3,4’dG 100 μM show a fibroblast-like
morphology and a flattened shape (panels A, D); cells in-
cubated with PBS exhibit a marked detachment from the
plate and the acquisition of a round shape (panel B).
Conversely, the simultaneous treatment with PBS and
Q3,4’dG 100 μM partially restores the aspect of untreated
cells, showing several cytoplasmic projections and a mostly
preserved cell body (panel C). Scale bar= 50 μM. b–c)
Western blot analysis demonstrates a significant decrease in
both Pancadherin (b) and FAK (c) protein expression in PBS
treated cells; the addition of Q3,4’dG 100 μM to PBS reverts
this phenomenon. The bar graph shows the computer assisted
quantification of the band intensity from three separate ex-
periments: data are normalized over the respective β actin
signal and are reported as mean ± SD, taking control as
100%; #p < 0.05 PBS vs. CTL, §p < 0.05 PBS+Q3,4’dG vs.
PBS, °p < 0.001 vs CTL.
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worth remembering that HSP cells reflect the heterogeneous cell com-
position of the striatal primordium, including both neuronal and glial
cells (Sarchielli et al., 2014). Therefore, it is to be hypothesized that
protection by Q3,4’dG occurs both by acting directly on the neuronal
component and regulating glial functions such as neuron mechanic and
trophic support, development of nerve fibers and inhibition of an in-
flammatory condition.
Another interesting finding arising from this study is a strong de-
crease of adhesion molecules, such as Pancadherin and FAK, in nutrient
deprivation, confirmed by the morphological data such as cell detach-
ment and cytoplasmic projections loss. Of note, Q3,4’dG addition op-
posed to the loss of cell adhesion and interaction with ECM.
Pancadherin has been identified as a protagonist of neuronal cell ad-
hesion, axonal sprouting, axon-dendritic contacts, synaptic plasticity
and rearrangement (Atalay et al., 2007, 2008). Studies of FAK in ner-
vous system have demonstrated its importance both during develop-
ment and in adult brain. In fact, several lines of evidence support FAK
as key component in regulating axon guidance, particularly axon out-
growth by its interaction with different extracellular molecules and
cytoskeleton. In addition, FAK expression in neurons is activated by
multiple adhesion proteins (e.g., integrins and NCAM) (Xiong and Mei,
2003; Navarro and Rico, 2014). It is noteworthy, that neutrophic fac-
tors in HSP cells are able to induce the expression of some integrins and
adhesion molecules, such as CD15, CD24, CD29 and CD56 (Sarchielli
et al., 2014). Therefore, we can speculate that Q3,4’dG may play a
neuroprotective role preserving directly the adhesion molecules or in-
directly stimulating the expression of neurotrophic factors. Interest-
ingly, our results showed also that the loss of cell adhesive abilities are
related to increased apoptosis in nutrient deprivation. Then Q3,4’dG
could protect against the common apoptosis, as previously reported,
and/or against its peculiar form anoikis. In fact, this is a programmed
cell death induced upon cell detachment from extracellular matrix and
FAK, being a key component of cell-substratum adhesion, has a fun-
damental role in impede anoikis (Lu and Rounds, 2012; Paoli et al.,
2013).
The identification of the molecular forms of quercetin circulating in
the blood and their pharmacological effects has often been discussed in
the light of its controversial results (Dajas, 2012; Graefe et al., 2001;
Prasain and Barnes, 2007; Lee and Mitchell, 2012). Quercetin is mainly
present in food and beverages as hydrophilic glycosides, that are scar-
cely absorbed and rapidly de-glycosidated by enterobacteria for the
intestinal absorption. Plasma samples revealed that quercetin circulates
in plasma only in conjugated form, as methylate, sulphate and glu-
curonide metabolites (Graefe et al., 2001). The issue of intestinal ab-
sorption is a key step and has previously been a point of discussion. In
vitro studies suggest that blood barrier is traversed both by quercetin
and probably by its glycosides (Zeng et al., 2011; Dajas, 2012; Faria
et al., 2014; Ishisaka et al., 2014; Dajas et al., 2015; Costa et al., 2016;
Sharma et al., 2016; Suganthy et al., 2016). Kelly (2011) reported that
the oral administration of quercetin to humans (50–150mg for 2
weeks) significantly increased plasma concentrations of quercetin. Its
accumulation as metabolite forms was observed after oral administra-
tion of quercetin (one month), in the brain tissue of rats and resulted
with antioxidant activity (Ishisaka et al., 2011). The study we addressed
on striatal neural cells is an in vitro study, so when transferred in vivo,
the various barriers such as the intestinal and blood brain barriers, that
the glycoside encounters if introduced orally and/or by the blood-
stream, should be considered. The positive results that we obtained
with Q3’,4dG in vitro are probably linked to the presence of two
monosaccharide units associated with the absence/decrease of toxic
effects as observed for other quercetin glycosides (Tenore et al., 2013;
Magalingam et al., 2014), so some strategies for transporting these
glycosylated flavonoids undisturbed in vivo should be considered.
Different types of liposomes have been utilized with success in cases of
experimental ischemia (Rivera et al., 2008) and recent studies de-
monstrated that several nanodelivery techniques, including solid lipid
nanoparticles, nanostructured lipid carriers, nanoliposomes, and na-
noniosomes can be used to obtain effective concentrations and con-
trolled delivery of nanobioactive compounds to the brain (Kelly, 2011;
Dajas et al., 2015, Caruana et al., 2016; Costa et al., 2016; Ganesan
et al., 2015; Suganthy et al., 2016).
It is to keep in mind that this is the first investigation on protective
effect of a single quercetin glycoside from Allium cepa on HSP cells
survival. Further investigations are necessary to better clarify the un-
derlying mechanisms. In addition, the effect of other abundant flavo-
noid components of Allium as Q4’dG and quercetin would be tested,
comparing them to each other, and evaluating if their mix may have an
enhanced action.
5. Conclusions
Our findings demonstrate that Q3,4’dG treatment has a beneficial
effect on HSPs survival in nutrient deprivation condition, leading to
reduction of apoptosis, and maintaining proliferation, morphology and
the adhesive capacities. Therefore, this study highlights a fundamental
neuroprotective role by Q3,4’dG, suggesting its possible implications in
sustaining striatal neural cells to prevent neurodegeneration (Cisbani
et al., 2013; Caruana et al., 2016). In addition, these findings may aid to
develop new pharmaceutical formulations, as there are not yet effective
therapies for neurodegenerative pathologies such as HD and PD.
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